THE EFFECT OF TENIDAP ON CYTOKINES, ACUTE-PHASE PROTEINS, AND VIRUS LOAD IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-INFECTED PATIENTS - CORRELATION BETWEEN PLASMA HIV-1 RNA AND PROINFLAMMATORY CYTOKINE LEVELS
Bj. Dezube et al., THE EFFECT OF TENIDAP ON CYTOKINES, ACUTE-PHASE PROTEINS, AND VIRUS LOAD IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-INFECTED PATIENTS - CORRELATION BETWEEN PLASMA HIV-1 RNA AND PROINFLAMMATORY CYTOKINE LEVELS, The Journal of infectious diseases, 176(3), 1997, pp. 807-810
Proinflammatory cytokines may be important in the pathogenesis of huma
n immunodeficiency virus type 1 (HTV-1) disease. Tenidap decreases int
erleukin (IL)-6, IL-1, and tumor necrosis factor (TNF) production by p
eripheral blood mononuclear cells and decreases IL-6 plasma levels in
rheumatoid arthritis patients, In this randomized double-blind study,
43 HIV-1-infected patients received tenidap (120 mg) or placebo daily
for 6 weeks and then crossed over to the alternative therapy for an ad
ditional 6 weeks. Mean entry CD4 cell count was 140/mu L. Analyses wer
e performed on cytokines, acute-phase proteins, virus load, and CD4 ce
ll counts. With the exception of small differences in plasma TNF level
s, tenidap had no significant effect on these indices. Significant cor
relations of plasma IL-6 and TNF levels with HTV-1 RNA were noted. Six
patients discontinued tenidap due to rash, The effects of tenidap in
HIV-1 infection contrast to results in arthritis patients, in whom ten
idap decreased plasma levels of IL-6 and acute-phase proteins.